TY  - JOUR 
AU  - Intranuovo, F.
AU  - Brunetti, L.
AU  - Delre, P.
AU  - Mangiatordi, G.F.
AU  - Stefanachi, A.
AU  - Laghezza, A.
AU  - Niso, M.
AU  - Leonetti, F.
AU  - Loiodice, F.
AU  - Ligresti, A.
AU  - Kostrzewa, M.
AU  - Brea Floriani, José Manuel
AU  - Loza García, María Isabel
AU  - Sotelo, E.
AU  - Saviano, M.
AU  - Colabufo, N.A.
AU  - Riganti, C.
AU  - Abate, C.
AU  - Contino, M.
PY  - 2023
SN  - 1520-4804
UR  - http://hdl.handle.net/20.500.11940/21397
AB  - Cannabinoid type 2 receptor (CB2R), belonging to the endocannabinoid system, is overexpressed in pathologies characterized by inflammation, and its activation counteracts inflammatory states. Fatty acid amide hydrolase (FAAH) is an enzyme responsible...
LA  - eng
KW  - Cannabinoids
KW  - Endocannabinoids
KW  - Receptor, Cannabinoid, CB2
KW  - Molecular Docking Simulation
KW  - Benzamides
KW  - Anti-Inflammatory Agents
KW  - Amidohydrolases
KW  - Cannabinoid Receptor Agonists
KW  - Receptor, Cannabinoid, CB1
TI  - Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase
DO  - 10.1021/acs.jmedchem.2c01084
T2  - Journal of Medicinal Chemistry
M2  - 235
KW  - AS Santiago
KW  - IDIS
VL  - 66
ER  -